Nonalcoholic fatty liver disease in overweight children and adolescents

Objective: To investigate the prevalence and characteristics of non‐alcoholic fatty liver disease (NAFLD) and identify predictors for NAFLD in an overweight paediatric population. Methods: The study group included 58 overweight (BMI‐SDS 3.37 ± 1) patients aged 8–18 years attending the paediatric obe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Paediatrica 2007-08, Vol.96 (8), p.1209-1213
Hauptverfasser: Sagi, R, Reif, S, Neuman, G, Webb, M, Phillip, M, Shalitin, S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To investigate the prevalence and characteristics of non‐alcoholic fatty liver disease (NAFLD) and identify predictors for NAFLD in an overweight paediatric population. Methods: The study group included 58 overweight (BMI‐SDS 3.37 ± 1) patients aged 8–18 years attending the paediatric obesity clinic. They underwent a clinical and biochemical work‐up and liver ultrasonography. Grading of liver steatosis severity was done according to discrepancy in ultrasonographic liver‐kidney densities. Results: The prevalence of NAFLD was 60.3%. There was a highly significant (p = 0.004) association between severity of obesity and the presence or absence of liver steatosis. The study cohort was divided into three groups: group 1 (patients with normal ultrasonographic liver structure and normal liver enzymes), group 2 (patients with ultrasonographic fatty liver and normal liver enzymes) and group 3 (patients with ultrasonographic fatty liver and elevated liver enzymes). The BMI‐SDS was significantly higher in group 3 compared to group 1 (4.2 ± 1.1 vs. 2.8 ± 0.9, p < 0.001). The rate of obesity complications was more prevalent in group 3 compared to groups 1 and 2 (p < 0.001). The insulin resistance index was higher in group 3 compared to group 1 (0.75 ± 0.2 vs. 0.47 ± 0.3, p < 0.05). Conclusions: The prevalence of NAFLD in our study cohort was high (60.3%). Patients with steatosis and elevated liver enzymes had a higher risk for obesity complications. Measurements of liver enzymes alone are insufficient, and liver ultrasonography is required for early identification of NAFLD.
ISSN:0803-5253
1651-2227
DOI:10.1111/j.1651-2227.2007.00399.x